Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Retroviral vector transduced B7-H3 CAR T cells |
| Synonyms | |
| Therapy Description |
Retroviral vector transduced B7-H3 CAR T cells are T cells engineered using a retroviral vector to express a chimeric antigen receptor (CAR) that targets B7-H3, which potentially decrease growth of B7-H3-expressing tumor cells (PMID: 31485480). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Retroviral vector transduced B7-H3 CAR T cells | CD276 Immune Cell Therapy 10 | Retroviral vector transduced B7-H3 CAR T cells are T cells engineered using a retroviral vector to express a chimeric antigen receptor (CAR) that targets B7-H3, which potentially decrease growth of B7-H3-expressing tumor cells (PMID: 31485480). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05474378 | Phase I | Retroviral vector transduced B7-H3 CAR T cells | B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme | Recruiting | USA | 0 |